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A B S T R A C T
Enabling the implementation of top down proteomic techniques within clinical workﬂows requires a
dramatic increase in sensitivity. It has been previously demonstrated that electrospray ionization (ESI)
becomes more efﬁcient with decreasing volumetric ﬂow rates at the emitter. Therefore, narrow inner
diameter (I.D.) columns used in front-end chromatographic separations yield increased sensitivity.
However, the smaller cross-sectional area of a narrow I.D. column places a larger fraction of the eluent in
ﬂuid communication with the electrode within the high voltage union that facilitates electrospray
ionization (ESI), leading to increased oxidation of solution-phase proteins. Oxidation of proteins alters
their chemical state of the protein, complicates data analysis, and reduces the depth of proteome
coverage attained in a typical top-down proteomics experiment. Excessive protein oxidation results in
poor deconvolution and exact mass calculations fromMS1 spectra, interferes with peak isolation for MS/
MS fragmentation, and effectively reduces sensitivity by splitting ion current. All of these factors
deteriorate top down mass spectral data quality, an effect that becomes more pronounced as column
diameter decreases. Artiﬁcial protein oxidation can also mislead investigations of in vivo protein
oxidation. All of these effects are accentuated in comparison to bottom up proteomics due to the
increased probability of having oxidizable residues within a particular species with increasing mass.
Herein, we describe a conﬁguration (which we term “Low Protein Oxidation (LPOx)”) for proteomics
experiments created by re-arranging liquid chromatography (LC) plumbing and present its application to
artiﬁcial protein oxidation and show a marked improvement in detection sensitivity. Using a standard
mixture of ﬁve intact proteins, we demonstrate that the LPOx conﬁguration reduces protein oxidation up
to 90% using 50mm I.D. columns when compared to a conventional LC plumbing conﬁguration with
50mm I.D. column. As a proof-of-concept study, at least 11 distinct proteoforms of serum Apolipoprotein
A1were detected with the LPOx conﬁguration. This innovative LC conﬁguration can be applied to the top
down identiﬁcation and characterization of proteoforms obscured by abundant artiﬁcial protein
oxidation at low ﬂowrates, all while using reduced amounts of valuable protein samples.
Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The analysis of intact proteins with high-resolution mass
spectrometry combined with post-data analysis has provided
qualitative and more recently, quantitative information on the
proteomes of various organisms [1–5]. Thorough amino acid
sequence coverage and post-translational modiﬁcation (PTM)
identity and location can be obtained from the combination of
highly accurate intact masses yielded by MS1 spectra and MS/MS
fragment ion masses generated by fragmentation, facilitating the
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transform mass spectrometer; AGC, automatic gain control; HCD, higher energy
collisional dissociation; MS, mass spectrometry; MS1, intact/precursor scan; MS2,
(or MS/MS); nLC, nano liquid chromatography; SDS, sodium dodecyl sulfate; ESI,
electrospray ionization; PTM, post-translational modiﬁcation; HDL, high density
lipoprotein; UV–LC, liquid chromatographywith ultra violet detector; NMR, nuclear
magnetic resonance; 2-DE, 2-dimensional electrophoresis; SOD, Superoxide
dismutase; PHM-L, Polyhydroxymethylene substituted by fat oxethylized alcohol;
RT, room temperature.
* Corresponding author. Tel.: +1 847 467 4362; fax: +1 847 467 3276.
E-mail address: n-kelleher@northwestern.edu (N.L. Kelleher).
http://dx.doi.org/10.1016/j.euprot.2015.05.005
1876-3820/Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
EuPA Open Proteomics 8 (2015) 40–47
Contents lists available at ScienceDirect
EuPA Open Proteomics
journal homepage: www.elsevier .com/ locate /euprot
discovery of proteoforms unique to speciﬁc biologic conditions [6].
As the capabilities of top down proteomics have expanded, the
approach is now beginning to realize its potential as a disruptive
clinical methodology. One of the most important, emerging roles
for top down proteomics in this capacity has been the discovery of
disease-related, proteoform-resolved biomarkers, which may
serve as diagnostic or prognostic indicators, targets for therapy,
and markers of therapeutic efﬁcacy [7].
Even after a series ofmajor advancements inmass spectrometry
instrumentation, including the development of high-resolution
mass spectrometers and nano-ﬂow liquid chromatography (nLC),
the limited amount of protein sample that can be obtained from
patients (biopsied tissue, sorted cells from blood, banked serum
from large scale epidemiologic studies, etc.) has remained a barrier
for intensive, large-scale biomarker research by top down
proteomics. Over the past several decades, the development and
application of narrow inner diameter columns to front-end LC
separations has presented an effective option to improve
sensitivity in sample limited situations [8–9]. In the past, Ye,
et al. showed that a 2.1mm I.D. column yields up to a seven-fold
increase in sensitivity compared to a 4.6mm I.D. column fora-,b-,
g-, and d-tocopherol analysis using micro ﬂow [10]. Emmett
reported that micro-ESI needles of 25–50mm inner diameter
coupledwith FT-ICR system producedmass spectra from amixture
of three neuroactive peptides at a concentration of 500 amol/mL in
biological salts with baseline separation, signal-to-noise ratio of
>10:1 and mass resolving power >5000 [11]. Further, Luo et al.
reported that reducing the inner diameter to 10mm monolithic
columns increased the sensitivity of peptide detection by 10-fold
using ﬂow rates as low as 10nL/min [12]. In Luo’s result, it was
shown that narrow I.D. analytical columns better concentrate low
sample volumes for optimal detection by LC–MS, and, when
combined with nano-ﬂow rates that enhance ionization efﬁciency,
result in >5000 different peptides identiﬁcation from 100ng of a
Shewanella oneidensis tryptic digest.
Typical top down proteomics experiments employ 100mm or
75mm I.D. columns connected via a vented tee conﬁguration to
bind, wash, and separate proteins for analysis (Fig. 1A) [13].
However, when narrower 50mm I.D. columns are applied to this
conﬁguration to take advantage of the known increase in
sensitivity for limited sample amounts, the unwelcome phenome-
non of protein oxidation occurs more readily than in 75mm I.D.
columns. The 2.2-fold reduction in cross-sectional area results in a
higher proportion of the mobile phase interacting with the ESI
electrode. As the eluting proteins pass through this junction, the
redox processes occurring at the electrode can lead to oxidation.
Oxidation of peptides and proteins during electrospray ionization
has been known for over 20 years [14]. Oxidation typically
manifests itself as a series of 15.995Da mass increases from the
original unmodiﬁed mass spectral peak of the proteoforms of
interest.
Protein oxidation is not only a chemical artifact of LC–MS but
also an important potential in vivo modiﬁcation [15,16]. Oxidative
stress associated with aging and certain disease conditions can
oxidize proteins and thereby modulate their functions to a
physiologically signiﬁcant degree, either by inhibiting enzymatic
and binding activities, increasing susceptibility to aggregation and
proteolysis, changing uptake rates by cells, or altering immunoge-
nicity [17]. For example,Wright et al. demonstrated that long-lived
Tyr-derived peroxides are formed on proteins exposed to 1O2, and
that these modiﬁed proteoforms may promote damage to other
targets via further radical generation [18,19]. Also, Yeong-Renn
et al. showed that protein oxidation of cytochrome c by reactive
halogen species enhances its peroxidase activity [20]. While the
natural, in vivo oxidation of proteins is clearly an important PTM
that may inform the study of various human diseases, it is
impossible to distinguish in vivo oxidation from the in situ protein
oxidation that occurs artiﬁcially at the high voltage union in LC–
ESI–MS. Therefore, it is important to minimize or eliminate
instrument-related protein oxidation in order to study in vivo
protein oxidation with top down LC–MS.
Apolipoprotein A1, as a major component of high-density
lipoproteins (HDL), is reported to protect against atherosclerosis
via several mechanisms, including its ability to mediate the ﬁrst
step in reverse cholesterol transport, the efﬂux of cholesterol from
lipid-ladenmacrophages [21]. Additionally, an inverse relationship
between Apolipoprotein A1 serum levels and coronary heart
disease has been observed [22,23]. Oxidation of Apolipoprotein A1
has been demonstrated both in vitro [24] and in vivo [25], and has
been shown to be functionally signiﬁcant, decreasing cholesterol
efﬂux in ex vivo assays of reverse cholesterol transport [23,25,26].
Mateos-Caceres et al. have reported on the ﬁve isoforms of plasma
apolipoprotein A1 in patients suffering from acute coronary
syndrome using 2-dimensional electrophoresis (2-DE), but the
method could not elucidate important information regarding the
PTMs present on these isoforms [27]. It is known that apolipopro-
tein A1 is processed to three different lengths, including a pro-form
(amino acids 19-276), a mature form (25-267), and a truncated
form (25-266), and can bemodiﬁed by in vivo oxidation atmultiple
methionine, tyrosine and tryptophan residues within the protein
as well as by N-linked glycosylation at Lys-263 [24,28,29]. There
are 26 reported natural apolipoprotein A1 forms which vary at 24
different amino acid positions, making the complete top down
analysis of apolipoprotein A1 in individual patients quite a
challenge [30–33]. The development of highly sensitive methods
to prevent in situ instrumental oxidation and then detect and
characterize oxidative proteoforms of apolipoprotein A1, not to
mention the myriad other proteins oxidized by biological
processes in vivo, remains an unmet need.
In this study, an LC conﬁguration using 50mm I.D. columns was
utilized to reduce artiﬁcial protein oxidation levels and increase
sensitivity for top downproteomic analysis. MS data for a standard
ﬁve protein mixture were obtained with the LPOx conﬁguration
using 50mm I.D. analytical columns and compared to the
conventional setting using both 75mm and 50mm I.D. columns.
As a proof-of-concept, human serum apolipoprotein A1 was
analyzed using the novel LPOx conﬁguration to determine its
performance and applicability to valuable clinical sample sets.
2. Materials and methods
2.1. Standard protein mixture
A “Top Down Standard” mixture containing 0.1 pmol ubiquitin,
0.5 pmol trypsinogen, 1 pmol myoglobin, and 0.5 pmol carbonic
anhydrase (all Sigma–Aldrich, St. Louis, MO) was freshly prepared
in LC–MS Buffer A (95% water, 5% acetonitrile, and 0.2% formic
acid). Superoxide dismutase (SOD) occurs as a contaminant from
the purchased preparation of carbonic anhydrase.
2.2. Apolipoprotein enrichment using PHM-L Liposorb absorbent
Two young male healthy donors provided serum for analysis in
a protocol approved by the Institutional Review Board at
Northwestern University (IRB No. STU00097261). Blood was
obtained by venipuncture into BD Serum Separator tubes (Becton
Dickinson, East Rutherford, NJ), gently inverted ﬁve times, allowed
to stand at room temperature for 30min, then centrifuged at
1100 g for 10min to separate the serum fraction. Serumwas then
stored at 80 C. Serum (20mL) and 4mg of PHM-L LIPOSORBTM
absorbent (Millipore; Billerica, MA) were combined in 1mL of
100mM ammonium bicarbonate (Sigma–Aldrich) and mixed in a
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shaking incubator for 30min at room temperature. After the
absorbent was washed 3 times with 100mM ammonium
bicarbonate, bound apolipoproteins were eluted with 100mL 5%
sodium dodecyl sulfate (SDS) solution. SDS in the sample was then
removed by protein precipitation in methanol, chloroform, and
water as previously described [13]. The resultant dried protein
pellet was reconstituted in 50mL of Buffer A (5% acetonitrile in
water +0.2% formic acid) before MS analysis.
2.3. Capillary plumbing
Flexible fused silica capillary tubing for trap columns (O.D.:
360mm, I.D.: 150mm) and analytical columns (O.D.: 360mm, I.D.:
50mm and 75mm) were purchased from Polymicro Technologies
(Phoenix, AZ). Polymeric reverse-phase (PLRP-S, dP = 5mm, pore
size =1000Å, Agilent Technologies; Santa Clara, CA) [34] was
packed in fritted capillary tubing to make trap columns (packing
length: 2 cm) and analytical columns (packing length: 15 cm) using
a home-made pressure cell. Spray emitters (360mm O.D., 50mm I.
D., 8mm tip, Cat. No: FS360-50-8-N-20) were purchased fromNew
Objective (Woburn, MA) andmicro tee assemblies (Cat. No: P-888)
for vented tees were purchased from Upchurch Scientiﬁc (Oak
Harbor, WA). Conventional LC plumbing was installed as shown in
Fig.1A. Brieﬂy, the trap column, vented tee, analytical column, high
voltage tee and spray emitter were assembled in order from the
switching valve. The novel LPOx plumbing was assembled as
shown in Fig. 1B. The stator for the 10-port switching valve (SV2)
(Cat. No: 6041.0012) was purchased from Dionex (Sunnyvale, CA).
The dimensions of all capillaries which have not been mentioned
are: O.D. 360mm and I.D 30mm. Valve switching of SV1 and SV2
were programmed into the LC method using the Chromeleon
chromatography data system (Dionex, version 6.8)
2.4. Mass spectrometry analysis
Resuspended protein fractions (5mL) were injected onto a trap
column using an autosampler (Dionex). A nanobore analytical
column (75mm or 50mm I.D.) was coupled to the trap in a vented
tee setup. For the conventional capillary setting, a Dionex Ultimate
3000 RSLCnano system was operated at a ﬂow rate of 2.5mL/min
for loading sample onto the trap. Proteins were separated on the
analytical column and eluted into the mass spectrometer using a
ﬂow rate of 300nL/min for 75mm I.D. column and 100nL/min for
50mm I.D. column using the following gradient: 5% B at 0min; 15%
B at 5min; 55% B at 55min; 95% B from 58 to 61min; 5% B from 64
to 80min (Solvent B: 5% water, 95% acetonitrile, 0.2% formic acid).
For the 50mm I.D. LPOx conﬁguration, all LC parameters were
identical to the conventional setting except the ﬂow rate (700nL/
min) and the use of a ﬂow restrictor (O.D.: 360mm, I.D: 10mm,
length: 10 cm). Measured ﬂow rate at the end of the emitter was
100nL/min.
Mass spectrometry data were obtained on an Orbitrap Elite
mass spectrometer ﬁtted with a custom nanospray ionization
source. For the MS method, the FTMS data were collected (4
microscans, m/z 500–2000, resolution 120,000). For data-depen-
dent MS/MS, the top 2 peaks in the full-scan FT spectrum were
fragmented using higher-energy collisional dissociation (HCD)
with normalized collision energy of 25, isolationwidth of 50m/z, 4
microscans and a resolving power of 60,000. Dynamic exclusion
was performed with a repeat count of 2, a repeat duration of 120 s
and an exclusion duration of 5000 s. Automatic gain control (AGC)
was set to 1E6 ions and the maximum injection time was set to 1 s
for both MS and MS/MS. A 15V offset in the source was used
throughout the entire experiment. The capillary temperature was
320 C and the spray voltage was set to 2.0 kV.
[(Fig._1)TD$FIG]
Fig. 1. Conventional LC capillary tubing and LPOx conﬁguration.
Conventional capillary plumbing consists of a trap column, vented tee, analytical column, high voltage tee and spray emitter in that order (A). In the LPOx conﬁguration, there
is an additional non-conductive switching valve between two vented tees and a restrictor is installed to control the split LC ﬂowat the ﬁrst vented tee. The location of the high
voltage tee (HVT) is between the ﬁrst vented tee and restrictor (B).
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2.5. Data processing
Data from the mass spectrometer were submitted to a
distributed version of ProSightPC 3.0 (Thermo Fisher Scientiﬁc;
Waltham, MA) using a custom database built from the ﬁve protein
sequences. Mass tolerances for both precursor ions and fragment
ions were set to 10ppm [3]. E-values and the number of fragment
ions (b and y ions only) reported in the ProSightPC 3.0 results were
used to benchmark conﬁdent proteoform identiﬁcations.
3. Results and discussion
3.1. High voltage tee arrangement and LC ﬂow splitting in the LPOx
conﬁguration
For the conventional capillary setting shown in Fig. 1A, only a
single switching valve (SV1)was used. During the LC loading step, a
2.5mL/min ﬂow brings sample into the trap column where
proteins are bound and washed. The resulting solvent waste goes
through the vented teewithout any applied ESI voltage. During the
gradient, an SV1 valve switch blocks the vented tee and proteins in
the trap column are eluted onto the analytical column and
separated at 300nL/min for 75mm I.D. column and 100nL/min
ﬂow for 50mm I.D. column, respectively.
In the LPOx conﬁguration, a high voltage tee is located prior to a
preliminary vented tee (VT1) connected to the trap column in a
branched conﬁguration (Figs.1 B, 2 A and B). During the LC loading
phase, a 2.5mL/min ﬂow from SV1 (4!3) containing sample
proteins can pass through VT1 (a! c), the trap column, and
another vented tee (VT2; a!b), and the waste is directed through
a second switching valve (SV2; 2!1) in the absence of high
voltage. During the gradient, SV1 changes position (2!3) and
initiates nano-ﬂow (700 nL/min). LC ﬂow is now divided into two
streams at VT1. First, the ﬂow stream from VT1 (a!b) to the high
voltage tee (a! c) can be controlled by the backpressure of an
installed restrictor. Second, the other LC ﬂow stream from VT1
(a! c) throughVT2 (a! c) can elute proteins from the trap column
and separate themon the reverse-phase analytical columnwithout
any direct contact with the high voltage electrode. A 10mm I.D.
fused silica capillary with a length of 10 cm was chosen as a
restrictor to modulate the ﬂow rate of VT1 (a! c) to 100nL/min.
A non-conductive stator for SV2 resolves an electrical grounding
issue when high voltage is applied to the system.
3.2. The novel LPOx conﬁguration with a 50mm I.D. column yielded
less oxidation of an intact protein mixture
The artiﬁcial oxidation of ﬁve proteins was investigated by
analysis of their MS1 spectra after LC separation through two
different analytical column diameters in the conventional and
LPOx conﬁgurations with triplicate in each case. As shown in
Fig. 3A, minor but distinct oxidation of ubiquitin, trypsinogen, and
[(Fig._2)TD$FIG]
Fig. 2. Diagrams of LPOx plumbing.
During the loading phase, sample from the auto sampler can be enriched on trap column via capillary ﬂow through VT1 (a! c) andwaste can be removed through VT2 (a! c)
linked to SV2 (2!1) (A). In this step, high voltage for ESI is off. After the valve position of SV1 is changed, one stream of the split nano ﬂow can go through VT1 (a!b), HVT
(a! c), the restrictor on SV2 (5!4), and waste out. The other nano ﬂow stream canmove through VT1 (a! c), VT2 (a! c), analytical column, and spray emitter in to theMS.
In this step, high voltage is applied and electrospray ionization can occur at the end of the spray emitter (B).
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carbonic anhydrasewas detected after their separation on a 75mm
I.D. analytical column in the conventional capillary setting. The
observed 9+ ubiquitin charge state at 954.41 m/z is an oxidized
form of the 9+ peak at 952.63 m/z. An extended series of oxidative
peaks appear at higherm/z from the unmodiﬁed peaks for SOD and
myoglobin.When separations were performedwith the 50mm I.D.
column in the conventional capillary setting (Fig. 3B), these
oxidative peaks signiﬁcantly increased for all ﬁve proteins. The
oxidation level of trypsinogen and carbonic anhydrase increased
more than those detected with the 75mm I.D. columns. This vast
increase in protein oxidation can be explained by the difference in
column cross-sectional area. As previously stated, the 2.2-times
smaller cross-sectional area and lower ﬂow rates result in higher
oxidation of liquid-phase proteins. As depicted in Fig. 3C, the LPOx
conﬁguration yielded minor or no oxidation for all ﬁve proteins. In
the LPOx conﬁguration, proteins do not make direct contact with
the high voltage electrode because it is located in a branched
conﬁguration upstream of the trap column, and the high voltage is
transmitted by the stream of liquid between the high voltage
source and VT1. The analysis was performed using MS1 (intact
protein mass spectra) as the primary readout of overall protein
oxidation levels. MS2 data were collected to show the increase in
conﬁdence for protein identiﬁcation of the unoxidized proteoform
(vide infra). Percentage of oxidation for each protein was shown in
Table 1. For ubiquitin, the percentage of oxidation in 75mm I.D. and
50mm I.D. conventional conﬁgurations were 12% and 73%,
respectively, and was decreased to 3% in LPOx conﬁguration with
a 50mm I.D. column. More signiﬁcant reduction of oxidation was
observed in superoxide dismutase and trypsinogen. In trypsino-
gen, 93% oxidation was observed using a 50mm I.D column with
conventional conﬁguration; this declined 2% in the 50mm I.D.
column with LPOx conﬁguration.
Database search results and MS parameters from the LPOx
conﬁguration and conventional setting using the 50mm I.D
column for ubiquitin and myoglobin were compared and are
shown in Fig. 4. In LPOx conﬁguration, an increase of unoxidized
fragment ions for each protein could be observed. For ubiquitin, the
number of observed fragment ions was 49.0 .9 and the FT
injection time was 0.30 0.02msec in LPOx conﬁguration and in
the conventional setting, the number of observed fragment ions
was 41.72.2 and FT injection time was 1.70 0.23msec. These
results were consistent for myoglobin (number of fragment ions:
16.0 4.68 for the conventional setting and 34.33.2 for the LPOx
conﬁguration, FT injection time: 0.40 0.06 for conventional
setting and 0.30 0.09 for LPOx conﬁguration). These results can
be inferred from the different peak shapes between the two
results. Peaks with high intensities and narrow widths demon-
strate that the mass spectrometer with AGC receives a higher ion
ﬂux and can trap ions in a shorter injection time; this facilitates the
accurate isolation of proteoform ions during MS/MS to produce
many fragment ions for characterization. All of these results
indicate that reduced artiﬁcial protein oxidation in the LPOx
[(Fig._3)TD$FIG]
Fig. 3. Zoomed spectra of ﬁve intact proteins in three LC capillary settings.
FT-MS1 spectra for ﬁve standard proteins were acquired in three conditions (75mm(A) and 50mm I.D. (B) analytical column in a conventional capillary setting and 50mm I.D.
column in the LPOx conﬁguration (C)) and zoomed peaks of speciﬁc charge states of each protein are shown. The Yaxis of each plot is relative intensity. Dotted vertical lines in
the spectra indicate the un-oxidized protein peaks.
Table 1
Percentage of oxidation for 5 standard proteins.
% Of oxidation Conventional conﬁguration LPOX conﬁguration
Protein 75mm I.D. 50mm I.D. 50mm I.D.
Ubiquitin 12.41 73.36 3.06
Superoxide 40.58 80.75 10.34
Trypsinogen 7.64 93.56 2.08
Myoglobin 16.02 68.84 6.06
Carbonic anhydrase 17.84 76.10 5.37
Peak areas of each protein ions in 3 conditions were measured using Xcalibur
software and percentage of oxidation was calculated. Percentage of oxidation was
calculated by dividing sum of oxidized protein peak area with sum of total peak
area.
44 K. Kim et al. / EuPA Open Proteomics 8 (2015) 40–47
conﬁguration can improve qualitative data analysis in top down
proteomics, and can be helpful for characterizing PTMs on intact
proteins.
3.3. Comparison of the LPOx conﬁgurationwith a 50mm I.D. analytical
column and conventional LC plumbing with a 75mm I.D. column
showed improvement in sensitivity
When artiﬁcial protein oxidation occurs, the unmodiﬁed peak
intensities decrease as the original species are distributed into
oxidative ion species. From this concept, it is reasonable to
conjecture that peak intensities in a conventional LC set-up are
lower than in the LPOx conﬁguration. In the conventional setting,
lower oxidation levels were observed on a 75mm I.D. column than
on a 50mm I.D. column, and trypsinogen and carbonic anhydrase
were less oxidized overall. Still, a comparison of the LPOx
conﬁguration with a 50mm I.D. column to the conventional
setting with the high-performing 75mm I.D. column reveals a
marked sensitivity improvement with LPOx. As shown in Fig. 5,
peak intensities of myoglobin at the two different settings indicate
that the 50mm I.D. LPOx conﬁguration yields increased sensitivity
7-fold over the 75mm I.D. conventional setting at identical sample
amounts.
3.4. Proof-of-concept: the LPOx conﬁguration reveals hidden serum
apolipoprotein A1 proteoforms
As a proof-of-concept for the LPOx conﬁguration performance
and application to clinical samples, apolipoprotein A1 was puriﬁed
from human serum and analyzed by top down FT–MS online with
HPLC conﬁgured in the LPOx conﬁguration with a 50mm I.D.
analytical column. As a point of comparison, the same experiment
was performed using the conventional LC setting with a 75mm I.D.
column. Fig. 6 depicts the ﬁve minute-averaged spectra obtained
from the 75mm I.D. column/conventional capillary setting and the
50mm I.D. column/LPOx conﬁguration. As seen in the conventional
setting experiment, several abundant oxidative peaks obscure the
original proteoform peaks in the 31+ charge state (Fig. 6A). It is
exceedingly difﬁcult to distinguish the true biological proteoforms
(especially those from in vivo oxidation experiments) from the
artiﬁcial oxidation forms, and the isolation of a single peak from
the spectrum for MS/MS fragmentation is technically impossible.
[(Fig._4)TD$FIG]
Fig. 4. Comparison of the conventional setting and LPOx conﬁguration in data quality.
The number of fragment ions (b- and y- ions only) reported by ProSightPC analysis, and FT injection time of ubiquitin and myoglobin in two conditions (50mm I.D. column
with the conventional capillary setting (gray bar) and 50mm I.D. column with the LPOx conﬁguration (black bar) were compared. The standard error of each condition was
calculated from triplicate runs and is shown above in the bar graph.
[(Fig._5)TD$FIG]
Fig. 5. Comparison of myoglobin peak intensity between the conventional setting with 75mm I.D. and LPOx with a 50mm I.D. column.
The 5min-averaged FT-MS1 spectrum for myoglobin from the LPOx conﬁguration with a 50mm I.D. column (upper spectrum) and from the conventional plumbing with a
75mm I.D. column (lower spectrum) is shown in a mirrored, reﬂective manner. The m/z and the charge states of each peak are shown at the tip of each peak.
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In the LPOx conﬁguration experiment with the 50mm I.D.
column, the reduction of artiﬁcial protein oxidation exposed
several distinct peaks representing hidden apolipoprotein A1
proteoforms (Fig. 6B). In just one charge state, at least 11 distinct
peaks representing different proteoforms of serum apolipoprotein
A1 were distinguishable in this spectrum. This number of
proteoform candidates exceeds that reported in any previous
studies [4,27]. If a very narrow isolationwindow is applied to yield
MS/MS data, it may be possible to derive PTM information and thus
fully characterize each proteoform from its resultant fragmenta-
tion data. This work to further investigate the nature of the unique
apolipoprotein A1 proteoforms revealed by LPOx–LC–MS and their
role in cardiovascular disease is currently in progress.
4. Conclusion
Narrow I.D. columns can accommodate low amounts of
valuable clinical samples and achieve higher sensitivity for top
down analysis, but issues involving increased levels of protein
oxidation have hindered their widespread application. The
rampant protein oxidation occurring in narrow I.D columns during
ESI not only impedes the investigation of in vivo protein oxidation
but also greatly reduces top down data quality. Overlapped
oxidative peaks result in poor mass deconvolution and also
complicate ion isolation in MS/MS fragmentation. The innovative
LPOx conﬁguration equippedwith a narrow 50mm I.D. column can
vastly reduce protein oxidation compared to conventional LC
capillary settings with 75mm and 50mm I.D. analytical columns.
The 50mm I.D. column LPOx conﬁguration even showed higher
peak intensities and improved sensitivity in intact protein
detection over the 75mm I.D. columns employed in the current
conventional conﬁguration in top down nLC–MS. Clearly, the LPOx
conﬁguration coupled with 50mm I.D. columns can reduce protein
sample loading amounts while maintaining high detection
sensitivity, making the conﬁguration applicable to clinical sample
analysis by top down proteomics.
As a proof-of-concept for improved clinical top down proteo-
mics employing the LPOx LC conﬁguration, we detected serum
apolipoprotein A1 proteoforms including natural oxidation forms
that can compose important clinical signatures for atherosclerosis
and cardiovascular disease using top down proteomics coupled
with the LPOx LC setting and a 50mm I.D. analytical column. The
results of this analysis suggested that there are more than 11
detectable peaks that correspond to proteoforms of serum
apolipoprotein A1 that may be physiologically relevant. In this
study, we demonstrated that the novel LPOx conﬁguration
effectively reduces artiﬁcial protein oxidation and not only
facilitates the investigation of biologically oxidized proteoforms,
but also the discovery of proteoforms in limited amounts of clinical
sample by top down proteomics.
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